CHARACTERISTIC | PLACEBO (N = 110) | CINEOLE (N = 110) |
---|---|---|
Age – yr | ||
Mean | 62.5 ± 10.2 | 62.2 ± 9.1 |
Range | 40 – 79 | 41 – 79 |
Sex – M/F | 75/35 | 66/44 |
Weight – kg | ||
Mean | 79 ± 16 | 79 ± 14 |
Range | 48 – 120 | 52 – 113 |
Height – m | ||
Mean | 1.71 ± 8.8 | 1.70 ± 8.0 |
Range | 1.48 – 1.90 | 1.54 – 1.92 |
Years since appearance of COPD | ||
Mean | 12.8 ± 9.7 | 13.6 ± 10.9 |
Range | 1 – 56 | 1 – 59 |
Severity of COPD [number of patients] | ||
Moderate COPD (II) | 69 | 68 |
Severe COPD (III) | 41 | 42 |
FEV1/VC [%] | 58.0 | 58.7 |
FEV1 [l] | 1.61 ± 0.5 | 1.62 ± 0.5 |
FEV1 % predicted value | 54.4 | 54.9 |
Reversibility (increase of FEV1 after inhalation of β-agonist) [%] | 5.5 | 4.5 |
Allergies (number) | 10 | 9 |
Pack years | 31.5 ± 19 | 31.3 ± 16 |